When you or someone you love hears the words “it’s cancer,” time becomes the most precious currency you have. Every day of delay can feel like a lifetime — and in many cases, it can affect outcomes.
One of the most common questions we hear from international patients considering treatment in China is: “How long will it actually take — from the moment I reach out, to the day I start treatment?”
This article answers that question with real data, real timelines, and a real patient story. We’ll walk you through the full journey — from initial contact to first treatment — and show you exactly where the waiting happens, and where it doesn’t have to.
The Global Reality: How Long Do Patients Wait at Home?
Before we look at China’s timeline, let’s be honest about what patients face in their home countries. The data is sobering.
United Kingdom — The 62-Day Target That Keeps Being Missed
The NHS has a constitutional standard: 85% of cancer patients should begin treatment within 62 days of an urgent GP referral. In practice, this target has not been met since December 2015. [Source: Cancer Research UK, April 2026]
In February 2026, only 68.6% of patients in England received their diagnosis and started treatment within 62 days. The 31-day standard (from decision-to-treat to first treatment) was also missed, at 93% against a 96% target. [Source: Cancer Research UK, “Cancer waiting times: Latest updates and analysis,” April 22, 2026]
The picture gets worse when you look at individual trusts. A Press Association analysis of NHS England data found that in 2025, only 3 out of 119 acute trusts met the 85% target. The bottom performers — including Mid & South Essex (45.4%), Sheffield Teaching Hospitals (50.1%), and Guy’s & St Thomas’ in London (55.1%) — treated barely half their cancer patients within the 62-day window. At several trusts, at least one in seven patients who began treatment in December 2025 had been waiting more than 104 days. [Source: The Independent, “Cancer patients waiting over 104 days for treatment,” February 25, 2026]
Across the UK, an estimated 107,000 cancer patients waited more than 62 days to start treatment in 2025. [Source: Yahoo News / Cancer Research UK, 2025]
A landmark study by University College London, published in The Lancet Oncology, compared access to radiotherapy and chemotherapy across Australia, Canada, Norway, and the UK. The finding: UK patients wait up to seven weeks longer to begin treatment than patients in comparable countries. [Source: The Guardian, “UK trails other countries on waiting times for cancer treatment, study finds,” February 27, 2024]
Canada — 30 Weeks and Climbing
In Canada, the Fraser Institute’s annual “Waiting Your Turn” report for 2024 recorded a median wait of 30.0 weeks from GP referral to treatment — the longest ever measured, and a 222% increase from the 9.3 weeks recorded in 1993. [Source: Fraser Institute, “Waiting Your Turn: Wait Times for Health Care in Canada, 2024,” December 2024]
Even for cancer-specific care, the waits are significant. Radiation oncology had a median wait of 4.5 weeks, and medical oncology 4.7 weeks — but these are after you’ve already waited to see a specialist. The total journey from GP referral to treatment can stretch to 30 weeks. For diagnostic imaging, patients waited a median of 16.2 weeks for an MRI and 8.1 weeks for a CT scan. [Source: Canadian Healthcare Technology, “Patients waiting longer than ever for procedures,” December 18, 2024]
Even in Ontario, the best-performing province, the median total wait was 23.6 weeks. In Prince Edward Island, it reached 77.4 weeks. [Source: Fraser Institute, 2024]
The Cost of Waiting
These aren’t just statistics. Research published in the BMJ estimated that a 4-week delay to cancer surgery leads to a 6-8% increased risk of death. [Source: BMJ, “Delays in cancer surgery and mortality,” 2020, Vol. 371, m4087]
For aggressive cancers, every week matters. And for patients who have already been waiting months in their home system, the question becomes: Is there a faster path?
The China Timeline: From Contact to Treatment
This is where China’s healthcare system offers a fundamentally different experience — not just in cost, but in speed. Here is the realistic timeline for an international patient working with myMedVia.
Phase 1: Initial Contact & Medical Record Review (Days 1–5)
Day 1: You reach out to myMedVia. A patient coordinator is assigned within hours. You are asked to upload your existing medical records — biopsy reports, pathology slides, imaging (CT, MRI, PET-CT in DICOM format), blood work, and any prior treatment history.
Days 2–3: Your records are forwarded to the international department of a partner Grade 3A hospital. A multidisciplinary team (MDT) reviews your case. In most cases, you receive a preliminary assessment and treatment recommendation within 48 hours. [Source: Fuda Cancer Hospital admission procedures — specialist review within 48 hours of receiving records]
Days 4–5: A detailed treatment plan and cost estimate are prepared. The hospital’s international center issues an official medical invitation letter (required for the S2 medical visa). myMedVia coordinates with the Chinese embassy or consulate in your country to expedite the visa process.
Time saved vs. home system: In the UK, the Faster Diagnosis Standard aims for 75% of patients to receive a diagnosis or have cancer ruled out within 28 days of referral. In Canada, simply getting a consultation with an oncologist can take weeks. In China, a specialist review happens in 2 days.
Phase 2: Travel & Arrival (Days 6–10)
Days 6–8: You travel to China. Most international patients arrive in Shanghai, Beijing, or Guangzhou — all cities with direct flights from major global hubs. myMedVia arranges airport pickup, accommodation (often within walking distance of the hospital), and a local SIM card or mobile data.
Day 9–10: You arrive at the hospital. An English-speaking patient liaison greets you. You complete registration and meet your attending physician. If your existing imaging is insufficient or outdated, same-day or next-day diagnostic imaging is scheduled.
Time saved vs. home system: In Canada, the median wait for an MRI is 16.2 weeks. In China, you can have one the same day you request it. [Source: Fraser Institute, 2024; China medical tourism industry data]
Phase 3: Diagnostic Confirmation & Staging (Days 10–14)
This is where China’s efficiency becomes most visible. In most Western public systems, each diagnostic step requires a separate referral, a separate appointment, and a separate wait.
In a Chinese Grade 3A hospital with an international center:
PET-CT scan: Scheduled within 24 hours. Results available the same day.Pathology review: If a second pathology opinion is needed, it is completed within 2–3 days. Many hospitals have in-house pathology labs that process biopsies within 24–48 hours.MDT consultation: The oncology team — including surgeons, radiologists, oncologists, and pathologists — meets to finalize your treatment plan. This happens within 1–2 days of completing diagnostics.Total for Phase 3: 3–5 days.
Time saved vs. home system: In the UK, the 28-day Faster Diagnosis Standard covers the period from urgent referral to diagnosis or rule-out. In China, the equivalent process — from arrival to confirmed diagnosis and staging — takes 3–5 days.
Phase 4: Treatment Initiation (Days 14–21)
Once the treatment plan is finalized, treatment begins quickly:
Chemotherapy/Immunotherapy: Can start within 24–48 hours of the MDT decision.Radiation therapy: Treatment planning (CT simulation, contouring, dosimetry) takes 2–3 days. First fraction typically delivered within 5–7 days of the decision.Surgery: Typically scheduled within 3–7 days, depending on preoperative preparation and the patient’s condition.CAR-T therapy: Cell collection (apheresis) can begin within days. Manufacturing time in China has been reduced to as little as 24–36 hours using FasTCAR technology, compared to 2–4 weeks in Western countries. [Source: ChinaCare Health Tours, “Cancer Treatment in China for Foreign Patients: 2026 Guide”]> Note on CAR-T costs: All-inclusive CAR-T packages in China (covering treatment, hospitalization, and monitoring) range from $50,000–$80,000, while the listed drug price for individual products is approximately $120,000–$180,000. See Articles 1 and 4 in this series for detailed cost breakdowns. > >
Total time from initial contact to first treatment: 14–21 days.
The Visual Timeline: A Side-by-Side Comparison
| Phase | NHS (UK) — Typical | Canada — Typical | China (via myMedVia) |
|---|---|---|---|
| GP referral to specialist consultation | 2–4 weeks | 8–20 weeks | N/A (direct specialist access) |
| Diagnostic imaging (MRI/CT/PET-CT) | 2–6 weeks | 8–16 weeks | Same day or next day |
| Diagnosis confirmation & staging | 4–8 weeks (28-day FDS target) | 4–12 weeks | 3–5 days |
| Treatment planning (MDT to decision) | 1–3 weeks | 1–4 weeks | 1–2 days |
| First treatment after decision | 1–4 weeks (31-day target: 93% met) | 2–5 weeks | 24 hours to 7 days |
| Total: Referral to first treatment | 62 days+ (target: 85%; actual: 68.6%) | 30 weeks median (210 days) | 14–21 days |
Sources: NHS England Cancer Waiting Times, February 2026; Fraser Institute Waiting Your Turn 2024; Cancer Research UK, April 2026; myMedVia patient pathway data.
A Note on Urgent vs. Elective Treatment
It’s important to distinguish between two scenarios:
Emergency/Urgent Treatment: In all three systems, patients with acute, life-threatening conditions (e.g., superior vena cava obstruction, spinal cord compression, acute leukemia with critical lab values) are prioritized. In the NHS, these patients are typically seen within 24–48 hours. In China, the same urgency applies.
Elective/Scheduled Treatment: This is where the gap widens dramatically. For patients with solid tumors that are progressing but not immediately life-threatening — the majority of cancer patients — the wait in the NHS and Canada can stretch into months. In China, these patients can access care within 2–3 weeks of initial contact.
The key insight: China’s advantage is not in emergency response — it’s in eliminating the “elective queue” that traps the majority of cancer patients in Western public systems.
Real Patient Story: David’s Journey from London to Shanghai
David, a 58-year-old marketing executive from London, was diagnosed with stage III non-small cell lung cancer in September 2025. His GP made an urgent cancer referral on September 15.
By mid-October — five weeks later — David had received a CT scan and a biopsy confirmation. His first oncology consultation was scheduled for November 12. His MDT recommended chemotherapy followed by immunotherapy. The earliest treatment slot he was offered: January 2026.
David’s total wait from referral to treatment: approximately 16 weeks — and that was faster than average for his trust.
Frustrated and anxious, David began researching alternatives. He contacted myMedVia on October 20.
Here is what happened next:
October 20: David uploaded his medical records to myMedVia’s platform.October 22: A thoracic oncology team at a partner hospital in Shanghai reviewed his case and confirmed he was a candidate for their immunotherapy protocol. A preliminary treatment plan and cost estimate were sent.October 24: The hospital issued a medical invitation letter. David applied for an S2 visa at the Chinese embassy in London.October 28: Visa approved.October 30: David flew to Shanghai. A myMedVia coordinator met him at the airport and escorted him to his accommodation near the hospital.October 31: David met his attending physician. A same-day PET-CT was scheduled and completed.November 1: The MDT reviewed David’s updated imaging and finalized his treatment plan: a combination of chemotherapy and a PD-1 inhibitor.November 3: David received his first infusion.Total time from initial contact to first treatment: 14 days.
David is now in his fourth month of treatment. His most recent scan shows a 40% reduction in tumor size. He returns to Shanghai every six weeks for his infusion cycle.
“The hardest part wasn’t the treatment — it was the waiting. Once I decided to come to China, everything moved. I went from feeling stuck to feeling like I was actually fighting back.”
What Makes This Speed Possible?
China’s ability to deliver fast cancer care is not accidental. Several structural factors make it possible:
1. High-volume, specialized centers. China’s top cancer hospitals treat tens of thousands of patients annually. The Cancer Hospital of the Chinese Academy of Medical Sciences in Beijing and Fudan University Shanghai Cancer Center each handle over 500,000 outpatient visits per year. High volume drives efficiency. [Source: ChinaCare Health Tours, 2026 Guide]
2. Integrated diagnostics. Unlike fragmented systems where each test requires a separate referral, Chinese Grade 3A hospitals offer same-day access to PET-CT, MRI, CT, ultrasound, and lab work under one roof.
3. Dedicated international centers. Major hospitals have separate international medical centers with dedicated staff, English-speaking coordinators, and streamlined processes for foreign patients. These centers operate outside the domestic queue system.
4. No GP gatekeeping. International patients access specialists directly — no waiting for a GP referral, no months-long wait for a consultation.
5. The “Hainan Shortcut.” The Boao Lecheng International Medical Tourism Pilot Zone in Hainan allows patients to access FDA/EMA-approved drugs and devices before they receive full Chinese NMPA approval. Over 500 innovative medicines are available through this pathway. [Source: ChinaCare Health Tours, 2026 Guide]
What This Means for You
If you are reading this and wondering whether China could be the right path for your cancer care, here is the honest answer:
If your cancer is slow-growing and you are receiving timely care in your home system, there may be no urgent need to travel.If you are facing a wait of months — or if your treatment options at home are limited — China offers a timeline that is measured in days and weeks, not months.If you are seeking access to therapies not yet available in your country — such as solid tumor CAR-T, Ivonescimab, or heavy ion therapy — China may be your fastest path to treatment.The decision to seek treatment abroad is deeply personal. But the data is clear: when it comes to time, China’s cancer care system offers an alternative that is not just faster — it is fundamentally different in how it approaches the patient journey.
Your Next Step
If you would like to understand what your personal timeline might look like, myMedVia offers a free medical record review. Send us your reports, and within 48 hours, we will tell you:
Whether your case is a good fit for treatment in ChinaWhich hospitals and specialists are best matched to your diagnosisA realistic timeline from contact to first treatmentA transparent cost estimateNo commitment. No pressure. Just information — so you can make the decision that is right for you.